Letters
Suboptimal prescribing in gout
Patient related factors are also important in treating gout
BMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e191 (Published 10 January 2012) Cite this as: BMJ 2012;344:e191
- Priyanka Chandratre, clinical research training fellow and honorary specialist registrar in rheumatology1,
- Edward Roddy, clinical senior lecturer in rheumatology and honorary consultant rheumatologist1,
- Christian Mallen, professor of general practice1
- 1Arthritis Research UK Primary Care Centre, Keele University, Keele ST5 5BG, UK
- p.chandratre{at}cphc.keele.ac.uk
The treatment of gout remains suboptimal—only 30% of primary care patients take urate lowering drugs.1 Lipworth and colleagues note that important reasons for this underuse include drug toxicity and poor patient adherence owing to the introduction of these drugs provoking gout attacks.2
However, the views and beliefs of patients about gout and urate lowering drugs also …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.